Infectious disease Archives

News and Trends 27 Apr 2016

Interviewing the CEO who uses Probiotics as Needle-free Vaccines

This is my first interview from BioTrinity 2016 in London. I met with Tom Johnston, CEO of Mucosis, to learn more about the needle-free vaccine platform he is developing. Mucosis is a biotechnology company based in Gröningen, Netherlands (a city we covered here for its medtech innovation). It was founded in 2007 and has raised over €20M so […]

April 27, 2016 - 1 minutemin - By Philip Hemme

Katharine dowson bioart science gallery hiv brain malformation glass

News and Trends 23 Apr 2016

BioArt : Katharine Dowson’s Brain Boxes, Crystal Chromosomes & HIV Vaccine Work

Represented by the GV Art Gallery in London, Katharine Dowson is a glass sculptor who is well established in the BioArt community as an Anatomical and medicine specialist. Katharine studied at the Royal College of Art and Camberwell in London, with a focus spanning to include the anatomical form (particularly the Nervous system) to infectious diseases and developmental research into a […]

April 23, 2016 - 4 minutesmins - By Dani Bancroft

News and Trends 21 Apr 2016

New CRISPR Tool can cut RNA too: Gene Editing just got even Easier!

The research team led by Emannuelle Charpentier, co-discoverer of the CRISPR/Cas9 system, has found that a new CRISPR system can also cleave RNA. Amazingly simple! The discovery of the CRISPR/Cas9 system revolutionised Biotechnology, unlocking a kind of ‘Golden age’ for gene editing – with a wide-reaching impact from therapeutics to SynBio. So, it’s no wonder that […]

April 21, 2016 - 3 minutesmins - By Denise Neves Gameiro

Vibiosphen biotech infectious disease pierre fabre

News and Trends 15 Apr 2016

Pierre Fabre partners for Open Innovation in Infectious Disease

Pierre Fabre has a new partnership for its Open Innovation programme based on an extensive plant library. It will now count with VibioSphen to develop new phyto-chemicals to fight infectious diseases. Pierre Fabre is the 3rd largest Pharma in France, employing over 10,000 people and generating revenues of over €2Bn. Lately, this mid-sized company made efforts […]

April 15, 2016 - 3 minutesmins - By Denise Neves Gameiro

News and Trends 13 Apr 2016

A New Cellular ‘Back Door’ has been found to fight Malaria

Paris & Strasbourg (France) researchers have discovered an ‘Achilles Heel’ for malaria: A specific molecule the parasite needs from the host. Could this spawn a new generation of Parasitic disease drugs? Malaria is a parasitic disease that was responsible for over 400,000 deaths worldwide just in 2015, according to the WHO – especially in sub-Saharan Africa. However, the current […]

April 13, 2016 - 3 minutesmins - By Denise Neves Gameiro

humabs influenza antibody infectious cellclone medimmune

News and Trends 24 Mar 2016

Novel Antibody for Influenza gets FDA Fast-Track Approval

Humabs (Switzerland) has gotten some serious recognition for its antibody platform, as its candidates for Influenza have received FDA fast-track designation. A biologic therapy for Influenza A has been granted Fast Track Designation by the FDA, a ‘programme to accelerate the treatment commercialisation. The therapy is based on an antibody (MEDI8852) that was initially developed by […]

March 24, 2016 - 3 minutesmins - By Denise Neves Gameiro

hiv virus vaccine la provence retroviral biosahntech anrs

News and Trends 23 Mar 2016

No, this French Startup didn’t Discover the Cure for HIV…

This is the story of a French doctor and his start-ups which have been trying to develop a cure for HIV for the last 10 years. The problem resides in exaggerating, not publishing data…and then repeating this process again and again. Last week, the professor Erwann Loret and his start-up Biosantech did a press conference to announce new “breakthrough” […]

March 23, 2016 - 3 minutesmins - By Philip Hemme

russia biotech hepatera maxwell mya hepatits b d phase ii b trials

News and Trends 22 Mar 2016

Biotech in Russia: Money and a New trial for Hepatitis

The Biotech MYR Pharma (Germany) is launching German-Russian phase IIb trials for chronic hepatitis B & D infections in partnership with Moscow’s Hepatera (Russia). MYR was founded in 2010 and is based in Burgwedel, Germany, supported by investors Maxwell Biotech and High-Tech Gründerfonds (HTGF). Hepatera, on the other hand, is actually the first Russian biotech we’ve encountered […]

March 22, 2016 - 2 minutesmins - By Dani Bancroft

News and Trends 21 Mar 2016

This CEO was responsible for the Only German Biotech IPO in 2015…

Whilst at the Sachs conference last week, I had the chance to meet with Oliver Schacht, the CEO of Curetis. It’s the only German Biotech which went public last year and this was a good enough reason to have a chat (the company is also really interesting, obviously). Curetis is based in Stuttgart in the […]

March 21, 2016 - 1 minutemin - By Philip Hemme

zika mosquito oxitcec fda swarm florida trial genetic engineering infectious disease

News and Trends 14 Mar 2016

Florida to release Genetically Engineered Mosquitoes to stop Zika Virus

Oxitec (UK) is on track to be allowed to trial their self-limiting, genetically engineered mosquitoes in the US – and stop the spread of Dengue and Zika. As a spin-off from Oxford University, Oxitec specialises in using genetic engineering to control insect pest populations with the ‘Sterile Insect Technique’. This is an interesting alternative to pesticides […]

March 14, 2016 - 3 minutesmins - By Denise Neves Gameiro

crispr mimivire aix nature virus synbio biotech

News and Trends 4 Mar 2016

This Megavirus has its own CRISPR-like Defense System

MIMIVIRE is the name French researchers have given to the immunity mechanism of mimivirus, and that they have now described in a new paper for Nature. What is a mimivirus? What is viral immunity? What is life? What is CRISPR? Well, for the last question, you should read our review on CRISPR. As for the rest, […]

March 4, 2016 - 3 minutesmins - By Denise Neves Gameiro

redhill biopharma israel gastrointestinal crohns cancer pancreatic rhb 104

News and Trends 3 Mar 2016

This Leading Israeli Biopharma is in Good Shape to fight Crohn’s Disease

RedHill Biopharma (Israel) is in a solid financial position to reap the benefits of several advanced trials in inflammatory gastrointestinal diseases, including Crohn’s. The company just released its financial statements, with some interesting highlights… Based in Tel-Aviv, RedHill is developing small molecule oral drugs for a variety of conditions connected to the gastrointestinal tract. It is listed […]

March 3, 2016 - 3 minutesmins - By Denise Neves Gameiro

Resources

Categories

The twelve hottest biotech companies in the Boston area

Biotech bankruptcies: what to expect in 2024 following a record year?

Approaches

Therapeutic areas

RNA editing set to take off: could it outperform gene editing?

Future of cancer treatment: what will therapy look like in 2034?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us